Cancer With Few or No Early Symptoms: Why Screening Matters

A tumor causes symptoms when it presses on something, blocks something, bleeds, or changes how an organ works. Early on, many tumors do none of these. They sit in a space with room to spare, in an organ that keeps functioning, and nothing hurts.

Location matters as much as size. The pancreas sits behind the stomach, liver and intestines, which is one of the reasons the National Cancer Institute gives for pancreatic cancer being hard to detect early. A small growth there cannot be seen or felt from outside.

No symptoms does not mean no disease. Often it just means early.

Pancreatic cancer. NCI states that early on, pancreatic cancer may not cause any signs or symptoms, making it hard to detect, and that when symptoms do appear they resemble many other illnesses. Those symptoms include jaundice (yellowing of the skin and the whites of the eyes), light-colored stools, dark urine, pain in the upper or middle abdomen and back, weight loss for no known reason, loss of appetite and fatigue.

Kidney cancer. NCI's summary of renal cell cancer says there may be no signs or symptoms in the early stages, and that signs and symptoms may appear as the tumor grows. Later signs include blood in the urine, a lump in the abdomen, a pain in the side that does not go away, loss of appetite, weight loss for no known reason and anemia.

Lung cancer. NCI states that sometimes lung cancer does not cause any signs or symptoms, and that it may be found during a chest x-ray done for another condition. When symptoms do appear they include a cough that does not go away or gets worse, chest discomfort or pain, trouble breathing, wheezing, blood in sputum, hoarseness, trouble swallowing, loss of appetite, unexplained weight loss and fatigue.

Ovarian cancer. There is no standard screening test. NCI says screening for ovarian cancer may not help a person live longer, and that using CA-125 blood levels together with transvaginal ultrasound does not decrease the number of deaths from the disease.

Real disease, no symptoms, worse outcomes when found late: that pattern is the whole reason screening exists. Screening looks for cancer before a person has any symptoms, which is the only window in which a silent cancer can be caught at all.

But screening helps only when a test exists that finds the disease early enough, reliably enough, to change what happens afterward. That condition is met for some cancers and not others, and the difference has nothing to do with how carefully anyone is paying attention.

NCI lists the screening tests shown to reduce deaths: mammography for breast cancer, shown to reduce breast cancer deaths among women ages 40 to 74; HPV and Pap testing for cervical cancer; colonoscopy, sigmoidoscopy and stool tests for colorectal cancer; and low-dose CT for lung cancer in people who have smoked heavily.

Of the four cancers above, lung cancer is the only one with a screening test recommended for a defined group.

The US Preventive Services Task Force recommends annual screening with low-dose computed tomography for adults aged 50 to 80 who have a 20 pack-year smoking history and who either currently smoke or quit within the past 15 years. That is a grade B recommendation, issued in March 2021.

The criteria are narrow and specific. People outside them are not covered by the recommendation, which is a statement about the populations the trials studied rather than about who deserves attention.

For ovarian and pancreatic cancer, no screening is offered to people at average risk. That is not an oversight. It reflects what happened when screening was tested.

Ovarian. The Task Force recommends against screening asymptomatic women who are not known to have a high-risk hereditary cancer syndrome such as a BRCA1 or BRCA2 mutation. It is a grade D recommendation from February 2018. Three large trials found no reduction in ovarian cancer deaths. False-positive rates ranged from roughly 4 percent to 44 percent depending on the test and the number of screening rounds, false positives led to surgery in women who did not have cancer, and up to 15 percent of those women had major surgical complications.

Pancreatic. The Task Force recommends against screening asymptomatic adults not known to be at high risk, a grade D recommendation from August 2019. It found no evidence that screening improves mortality, and no accurate, validated screening test.

Kidney. Kidney cancer does not appear on NCI's list of cancers with screening tests shown to reduce deaths, and no general screening test is offered. Many kidney tumors are found by accident, on scans ordered for something else entirely.

A grade D means a body of evidence concluded that the harms outweigh the benefits for people at average risk. It says nothing about people with a strong family history or a known genetic syndrome, who fall outside these recommendations and are usually managed differently.

Every symptom listed above is common, and is usually caused by something other than cancer. Abdominal pain, fatigue, cough and appetite changes are among the most frequent reasons people see a doctor at all.

Two features tend to matter more than the symptom itself: persistence and change. Something that keeps going for weeks without an obvious explanation, or a clear shift from what is normal for you, is worth describing to a clinician, along with how long it has lasted and whether it is getting worse. Bringing dates rather than impressions makes the conversation more useful.

That is a different activity from scanning yourself for disaster. Constant self-surveillance is exhausting, and it does not surface anything that a plain description of a persistent change would miss. The useful version is low-effort: notice, note when it started, and say so.

• Does my family history or any known genetic condition place me outside average-risk recommendations?
• Do I meet the criteria for lung cancer screening, and what would it involve?
• I have had this symptom for several weeks. What could explain it, and what would help rule things out?
• If a scan done for another reason showed an incidental finding, how would that be followed up?